Recombinant Haemophilus ducreyi Fumarate reductase subunit D (frdD)

Shipped with Ice Packs
In Stock

Description

Introduction to Haemophilus ducreyi

Haemophilus ducreyi is an obligate human pathogen and the causative agent of chancroid, a sexually transmitted genital ulcerative disease . As a gram-negative bacterium, H. ducreyi has evolved specialized mechanisms for survival within the human host, including various virulence factors and metabolic adaptations. Among these adaptations, the anaerobic respiration machinery plays a crucial role in allowing the organism to thrive in oxygen-limited environments during infection processes. Understanding the molecular components of this machinery, including fumarate reductase complexes, provides valuable insights into H. ducreyi pathogenesis and potential therapeutic targets.

Structure and Function of Fumarate Reductase

Fumarate reductase is a membrane-bound enzyme complex that catalyzes the reduction of fumarate to succinate during anaerobic respiration. This process represents the terminal step in electron transport chains utilizing fumarate as the final electron acceptor rather than oxygen. The enzyme complex typically consists of multiple subunits with distinct functions:

  • Subunit A (FrdA): The flavoprotein containing the catalytic site

  • Subunit B (FrdB): Contains iron-sulfur clusters for electron transfer

  • Subunits C and D (FrdC and FrdD): Membrane anchor proteins that secure the complex to the cytoplasmic membrane

The D subunit specifically functions as one of the membrane anchors, containing transmembrane helices rich in hydrophobic amino acids that facilitate integration into the lipid bilayer.

Fumarate Reductase in Haemophilus ducreyi

Proteomic analysis of H. ducreyi has confirmed the presence of fumarate reductase components in this pathogen. Specifically, the FrdA subunit has been identified in comparative proteomic studies, revealing its differential expression under various conditions . In a porin-deficient mutant of H. ducreyi (35000HP::P2AB), FrdA showed a 4.2-fold increase in expression compared to the wild-type strain, suggesting that alterations in membrane permeability influence the regulation of anaerobic respiration machinery .

Table 1: Identified Fumarate Reductase Components in Haemophilus ducreyi

ProteinNCBI RefSeq AccessionFunctionCOG AssignmentNumber of PeptidesFold Change in Expression
FrdANP_872657.1Fumarate reductase (flavoprotein subunit)C24.2

Note: COG assignment C refers to Energy production and conversion. Fold change indicates increased expression in porin-deficient mutant compared to wild-type.

Expression Systems and Methodology

The production of recombinant bacterial membrane proteins, including fumarate reductase components, presents specific challenges due to their hydrophobic nature and complex folding requirements. Based on established methodologies for similar proteins, recombinant production of H. ducreyi FrdD would likely involve:

  1. Gene cloning into an appropriate expression vector

  2. Fusion with affinity tags (such as His-tag) to facilitate purification

  3. Expression in bacterial hosts (commonly Escherichia coli)

  4. Optimization of growth conditions to enhance protein yield

  5. Purification using affinity chromatography

  6. Stabilization in appropriate buffer systems

For example, recombinant fumarate reductase subunit D from V. vulnificus has been successfully produced with an N-terminal His-tag in E. coli, achieving greater than 90% purity as determined by SDS-PAGE . The protein was lyophilized and could be reconstituted in deionized sterile water to concentrations of 0.1-1.0 mg/mL, with recommended addition of 5-50% glycerol for long-term storage .

Role in Anaerobic Energy Metabolism

The fumarate reductase complex plays a vital role in the anaerobic energy metabolism of many bacteria, allowing them to generate ATP in the absence of oxygen by using fumarate as a terminal electron acceptor. In H. ducreyi, this metabolic capability may be particularly important during infection, as the bacteria encounter microaerobic or anaerobic environments within host tissues.

The upregulation of FrdA in porin-deficient H. ducreyi mutants suggests a metabolic adaptation response, potentially compensating for altered membrane permeability by enhancing alternative energy-generating pathways . This adaptation may represent a survival strategy under stress conditions, highlighting the importance of fumarate reductase in bacterial resilience.

Coordinated Regulation with Other Metabolic Enzymes

Proteomic analysis of H. ducreyi reveals that changes in fumarate reductase expression occur in concert with alterations in other metabolic enzymes. The porin-deficient mutant showing increased FrdA expression also exhibited changes in multiple proteins involved in central metabolism, including:

  • Energy production proteins (RnfC, iron-sulfur binding NADH dehydrogenase)

  • TCA cycle enzymes (Kgd, alpha-ketoglutarate decarboxylase)

  • Pyruvate metabolism components (AceF, dihydrolipoamide acetyltransferase; AceE, pyruvate dehydrogenase)

This coordinated regulation suggests a comprehensive metabolic remodeling in response to membrane stress, with fumarate reductase functioning as part of an integrated adaptive response.

Potential as a Research Tool

Recombinant H. ducreyi FrdD would serve as a valuable tool for fundamental research in several areas:

  1. Structural biology of membrane protein complexes

  2. Mechanisms of anaerobic respiration in pathogenic bacteria

  3. Evolutionary relationships between fumarate reductase systems across bacterial species

  4. Development of in vitro assay systems for electron transport chain components

Such research could illuminate not only the specific biology of H. ducreyi but also broader principles of bacterial bioenergetics and membrane protein function.

Implications for Pathogenesis and Therapeutic Development

Understanding the structure and function of H. ducreyi fumarate reductase has potential implications for both pathogenesis research and therapeutic development:

  1. As a component of anaerobic respiration, fumarate reductase may contribute to bacterial survival during infection, particularly in oxygen-limited microenvironments.

  2. The differential regulation of fumarate reductase in response to membrane stress suggests its involvement in adaptive responses that may enhance pathogen resilience.

  3. The membrane-associated nature and essential metabolic function of fumarate reductase makes it a potential target for antimicrobial development, particularly for compounds that could disrupt anaerobic energy generation.

  4. Structural studies of recombinant FrdD could facilitate structure-based drug design approaches targeting this protein or its interactions within the fumarate reductase complex.

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them during order placement. We will accommodate your request whenever possible.
Lead Time
Delivery times may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery details.
Note: All proteins are shipped with standard blue ice packs unless otherwise specified. If you require dry ice shipping, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents are at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer components, storage temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during the production process. If you have a specific tag type in mind, please inform us, and we will prioritize developing the specified tag.
Synonyms
frdD; HD_0034; Fumarate reductase subunit D; Quinol-fumarate reductase subunit D; QFR subunit D
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-114
Protein Length
full length protein
Species
Haemophilus ducreyi (strain 35000HP / ATCC 700724)
Target Names
frdD
Target Protein Sequence
MNKQDPKRSNEPPVWLMFSAGGTISAICFPVLILILGILLPLGLIPMDNIIVFAHTWLGK LVILAVTIFPMWAGMHRVHHGLHDLKIHLPASGWLFYGLSTLYSIVVLFAVIAL
Uniprot No.

Target Background

Function
Anchors the catalytic components of the fumarate reductase complex to the cell membrane and binds quinones.
Database Links

KEGG: hdu:HD_0034

STRING: 233412.HD0034

Protein Families
FrdD family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the primary function of Fumarate reductase subunit D in Haemophilus ducreyi?

Fumarate reductase subunit D (frdD) appears to be primarily involved in anchoring the catalytic components of the fumarate reductase complex to the cytoplasmic membrane. This membrane-anchoring function is critical for the proper orientation and functioning of the enzyme complex within the bacterial cell. While most research has focused on related species like H. influenzae, the FrdD protein serves similar structural roles across the Haemophilus genus, forming part of the membrane anchor that positions the catalytic domains appropriately for electron transfer processes .

The FrdD subunit belongs to the broader FrdD protein family, which is characterized by similar membrane-spanning domains that facilitate the anchoring process. The protein's relatively small size (around 12.6 kDa in H. influenzae) and hydrophobic composition make it well-suited for integration into the bacterial cytoplasmic membrane .

How does the frdD subunit differ structurally from other fumarate reductase components?

Unlike the catalytic subunits of fumarate reductase (particularly subunit A which contains the FAD cofactor), frdD is a relatively small (approximately 114 amino acids in H. influenzae) hydrophobic protein that integrates into the cytoplasmic membrane. The protein contains multiple transmembrane domains that facilitate its membrane-anchoring function .

The primary amino acid sequence of frdD from H. influenzae (strain 86-028NP) is:
MVDQNPKRSGEPPVWLMFGAGGTVSAIFLPVVILIIGLLLPFGLVDAHNLITFAYSWIGKLVILVLTIFPMWCGLHRIHHGMHDLKVHVPAGGFIFYGLATIYTVWVLFAVINL

This sequence reveals the highly hydrophobic nature of the protein, which contrasts with the more hydrophilic catalytic subunits. While specific structural data for H. ducreyi frdD is limited, sequence homology suggests similar structural properties across Haemophilus species.

What techniques can be used to express and purify recombinant frdD from Haemophilus ducreyi?

Expression and purification of recombinant frdD requires specialized approaches due to its hydrophobic nature and membrane association. A methodological approach includes:

  • Gene Cloning: The frdD gene can be amplified using PCR with specific primers designed based on the H. ducreyi genome sequence. The amplified product can then be cloned into an expression vector, such as pCR2.1-TOPO or similar vectors that have been successfully used for other fumarate reductase components .

  • Expression Systems: E. coli-based expression systems are commonly used, with BL21(DE3) or similar strains that provide controlled expression of potentially toxic membrane proteins. For membrane proteins like frdD, expression conditions must be carefully optimized, often using lower temperatures (16-20°C) and reduced inducer concentrations .

  • Purification Strategy:

    • Membrane fraction isolation through differential centrifugation

    • Solubilization using mild detergents (DDM, LDAO, or Triton X-100)

    • Affinity chromatography using His-tag or other fusion tags

    • Size exclusion chromatography for final purification

  • Verification: SDS-PAGE analysis, mass spectrometry, and functional assays to confirm the identity and integrity of the purified protein .

When working with recombinant frdD, it's essential to maintain the protein in a detergent environment throughout the purification process to prevent aggregation and preserve the native conformation.

How can enzymatic activity of fumarate reductase be measured in research settings?

Fumarate reductase activity can be measured through several complementary approaches:

  • Spectrophotometric Assays:

    • Monitoring NADH consumption in the presence of fumarate at 340 nm, as demonstrated in A. pleuropneumoniae studies .

    • Following the reduction of artificial electron acceptors like 2,6-dichloroindophenol (DCIP) with phenazine ethosulfate as mediator.

  • Direct Measurement of Fumarate Reduction:

    • Measuring the rate of fumarate conversion to succinate using HPLC or other analytical techniques.

    • Using reduced benzyl viologen (BV+) as electron donor and measuring fumarate reduction rates .

  • FAD Reduction Monitoring:

    • Tracking optical changes of flavin at 460 nm during succinate oxidation or fumarate reduction .

Comparative activity data shows striking differences between isolated flavoprotein subunits and complete enzyme complexes:

Protein usedSuccinate-DCIP reductase, k<sub>cat</sub><sup>app</sup>BV<sup>+</sup>-fumarate-reductase activity
Complex IIFlavoproteinComplex II
s<sup>-1</sup>fum/s
E. coli
QFR27 ± 0.5197 ± 3
FrdA0.16 ± 0.01

These measurements reveal that isolated flavoprotein subunits have significantly lower catalytic activity (300-1000 fold) compared to fully assembled enzyme complexes .

What methods can be used to generate and validate frdD deletion mutants?

Creating and validating frdD deletion mutants involves several critical steps:

  • Construction of Deletion Vector:

    • Amplify upstream and downstream fragments flanking the frdD gene

    • Clone these fragments into a suitable vector system (e.g., pCR2.1-TOPO)

    • Create a construct with an in-frame deletion to minimize polar effects on downstream genes

  • Mutant Generation:

    • Introduce the deletion construct into H. ducreyi via conjugation (similar to the approach used for A. pleuropneumoniae with E. coli β2155)

    • Select for integrants using appropriate antibiotic markers

    • Screen for double crossover events that result in gene replacement

  • Validation Techniques:

    • PCR screening to identify colonies with the expected genetic profile

    • Southern blotting to confirm deletion and absence of unintended insertions

    • Nucleotide sequencing of the recombination site

    • Pulsed-field gel electrophoresis to confirm absence of genomic rearrangements

  • Phenotypic Confirmation:

    • Enzymatic assays to demonstrate the absence of fumarate reductase activity

    • Complementation in trans using a plasmid carrying the wild-type frdD gene to restore function

This methodology ensures that the observed phenotypes can be attributed specifically to the frdD deletion rather than to polar effects or unintended genomic alterations.

What is the potential of fumarate reductase as an antimicrobial target in Haemophilus infections?

Fumarate reductase represents a promising antimicrobial target for several reasons:

  • Essential Metabolic Function: The enzyme is critical for anaerobic respiration, which many pathogens rely on in host environments with limited oxygen availability.

  • Precedent in Other Organisms: Fumarate reductase has been identified as a potential therapeutic target in Helicobacter pylori, though the study noted that "none of the three known inhibitory compounds available were suitable" . This suggests both the validity of the target and the need for development of more effective inhibitors.

  • Structural Distinctiveness: The bacterial fumarate reductase differs significantly from mammalian succinate dehydrogenase, despite catalyzing related reactions, providing an opportunity for selective targeting.

  • Metabolic Vulnerability: Inhibition of fumarate reductase could disrupt the bacterium's ability to generate energy under anaerobic conditions, potentially attenuating infection.

Development strategies should focus on:

  • Structure-based drug design targeting the active site of the catalytic subunit

  • Compounds that disrupt the assembly of the fumarate reductase complex

  • Molecules that could destabilize the membrane anchoring function of frdD

The success of such approaches would depend on developing compounds with appropriate specificity, bioavailability, and pharmacokinetic properties suitable for treating Haemophilus infections.

How does the catalytic activity of isolated fumarate reductase subunits compare to the complete enzyme complex?

Research has revealed striking differences between isolated fumarate reductase subunits and complete enzyme complexes:

  • Dramatic Activity Reduction: Isolated flavoprotein subunits exhibit 300-1000 fold lower catalytic activity compared to fully assembled complexes. For example, E. coli QFR complex shows a k<sub>cat</sub><sup>app</sup> of 27 s<sup>-1</sup> for succinate-DCIP reductase activity, while the isolated FrdA subunit shows only 0.16 s<sup>-1</sup> .

  • Reaction Kinetics: The rate constants for FAD reduction by succinate in isolated flavoproteins (approximately 0.14 ± 0.02 s<sup>-1</sup>) are significantly slower than in complete complexes. Similarly, the reoxidation of reduced flavoproteins by fumarate occurs at rates of about 0.15 ± 0.02 s<sup>-1</sup> .

  • Electron Transfer Efficiency: The complete enzyme complex facilitates efficient electron transfer from substrate to terminal electron acceptors through its multiple subunits. Without the iron-sulfur clusters and membrane anchor subunits (including frdD), this electron transfer pathway is severely compromised .

  • Substrate Binding: Despite the low activity, isolated flavoproteins retain their ability to bind substrates such as fumarate, as demonstrated by spectral shifts similar to those observed in complete complexes .

What molecular mechanisms underlie the relationship between fumarate reductase and bacterial immune evasion?

While not directly established for fumarate reductase, research on H. ducreyi provides insights into potential connections between metabolism and immune evasion:

H. ducreyi has developed sophisticated mechanisms to evade host immune responses, particularly by inhibiting phagocytosis through interference with Src family protein tyrosine kinases in immune cells. Specifically, H. ducreyi targets the phosphorylation and catalytic activity of Lyn and Hck, two critical kinases involved in FcγR-mediated phagocytosis .

The potential relationship between fumarate reductase and immune evasion may involve:

  • Metabolic Adaptation: Fumarate reductase allows bacteria to generate energy under anaerobic conditions, potentially supporting the production of virulence factors that mediate immune evasion.

  • Microenvironment Modification: The catalytic action of fumarate reductase may alter the local microenvironment of infection sites, potentially affecting immune cell function.

  • Reactive Oxygen Species (ROS) Management: Research shows that unassembled flavoprotein subunits generate little ROS . The complete fumarate reductase complex likely helps manage oxidative stress during infection, potentially contributing to survival against host immune defenses.

How do environmental conditions affect the expression and activity of frdD in Haemophilus ducreyi?

The expression and activity of fumarate reductase components, including frdD, are likely regulated in response to environmental conditions, particularly oxygen availability. Though specific data for H. ducreyi frdD regulation is limited, several general principles can be inferred:

  • Oxygen-Dependent Regulation: Fumarate reductase expression is typically upregulated under low-oxygen conditions when bacteria shift to anaerobic respiration. This regulation often involves global transcriptional regulators responsive to oxygen concentration.

  • Nutrient Availability Effects: The availability of alternative electron acceptors and carbon sources can influence fumarate reductase expression through complex regulatory networks.

  • Host Environment Adaptation: Within the host, H. ducreyi encounters various microenvironments with different oxygen tensions and nutrient profiles. The regulation of fumarate reductase likely plays a role in adaptation to these changing conditions.

  • Temperature and pH Sensitivity: Environmental factors such as temperature and pH can affect both the expression of fumarate reductase genes and the catalytic activity of the enzyme complex.

For research applications, it's important to consider these environmental variables when designing experiments involving recombinant frdD or when studying the native enzyme in H. ducreyi. Experimental conditions should be carefully controlled and reported to ensure reproducibility and physiological relevance.

What are the challenges in maintaining structural integrity of recombinant frdD during experimental procedures?

Working with recombinant frdD presents several technical challenges due to its membrane protein nature:

  • Maintaining Membrane Protein Solubility: As a membrane-anchoring protein, frdD has hydrophobic domains that can cause aggregation when removed from a membrane environment. Researchers must carefully select appropriate detergents for solubilization and purification .

  • Preserving Native Conformation: The function of frdD depends on its correct folding and integration into membranes. Experimental conditions must be optimized to maintain this native conformation during isolation and subsequent studies.

  • Complex Assembly Considerations: Since frdD functions as part of a multi-subunit complex, studying its properties in isolation may not fully represent its behavior in vivo. Reconstitution experiments with other fumarate reductase components may be necessary for certain functional studies.

  • Expression System Selection: Heterologous expression of membrane proteins like frdD often results in low yields or inclusion body formation. Selection of appropriate expression systems (e.g., specialized E. coli strains) and optimization of expression conditions are critical for success .

These technical considerations highlight the importance of specialized approaches when working with membrane proteins like frdD to ensure that experimental results accurately reflect the protein's native properties and functions.

How can protein-protein interactions between frdD and other fumarate reductase subunits be studied?

Investigating protein-protein interactions between frdD and other fumarate reductase subunits requires specialized techniques suitable for membrane protein complexes:

  • Co-Immunoprecipitation (Co-IP):

    • Expressing tagged versions of frdD and other subunits

    • Using antibodies against these tags to pull down protein complexes

    • Analyzing the composition of these complexes by Western blotting or mass spectrometry

  • Crosslinking Studies:

    • Employing chemical crosslinkers of varying lengths to stabilize protein-protein interactions

    • Analyzing crosslinked products using SDS-PAGE followed by mass spectrometry to identify interaction sites

  • Förster Resonance Energy Transfer (FRET):

    • Creating fluorescently labeled versions of frdD and interacting partners

    • Measuring energy transfer as an indication of proximity between proteins

    • This technique is particularly valuable for studying interactions in membrane environments

  • Bacterial Two-Hybrid Systems:

    • Adapted for membrane proteins, these systems can detect interactions between frdD and other subunits in a cellular context

    • Results can be validated using complementary biochemical approaches

  • Reconstitution Studies:

    • Purifying individual subunits and systematically reconstituting the complex

    • Measuring enzymatic activity as a functional readout of successful complex formation

    • Comparing activities of partial and complete complexes to understand the contribution of each subunit

These techniques provide complementary information about the interaction network within the fumarate reductase complex and can help elucidate the specific role of frdD in complex assembly and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.